Article
Emerging drugs in the treatment of pancreatic cancer.
Expert opinion on emerging drugs - 1 Jun 2009
Mahalingam Devalingam, Kelly Kevin R, Swords Ronan T, Carew Jennifer, Nawrocki Steffan T, Giles Francis J
Abstract excerpt
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related death in the US. However, there is a growing belief that novel biological agents could improve survival of patients with this cancer. Gemcitabine-based chemotherapy remains the cornerstone treatment for advanced pancreatic cancers. So far, the current targeted agents that have been used in combination with gemcitabine have failed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.